News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,420 Results
Type
Article (87794)
Company Profile (824)
Press Release (778785)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233181)
Career Advice (4144)
Deals (39844)
Drug Delivery (144)
Drug Development (91370)
Employer Resources (203)
FDA (18364)
Job Trends (17415)
News (397744)
Policy (39953)
Tag
Academia (3006)
Academic (2)
Accelerated approval (30)
Adcomms (35)
Allergies (136)
Alliances (56981)
ALS (171)
Alzheimer's disease (1763)
Antibody-drug conjugate (ADC) (312)
Approvals (18491)
Artificial intelligence (583)
Autoimmune disease (136)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (192)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (628)
Cancer (4745)
Cardiovascular disease (414)
Career advice (3566)
Career pathing (40)
CAR-T (293)
CDC (59)
Celiac Disease (1)
Cell therapy (791)
Cervical cancer (37)
Clinical research (76631)
Collaboration (1627)
Company closure (5)
Compensation (1085)
Complete response letters (65)
COVID-19 (2980)
CRISPR (93)
C-suite (751)
Cystic fibrosis (148)
Data (5905)
Decentralized trials (2)
Denatured (69)
Depression (133)
Diabetes (502)
Diagnostics (7178)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (278)
Drug pricing (208)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99902)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134580)
Executive appointments (1011)
FDA (21273)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1453)
Gene editing (203)
Generative AI (60)
Gene therapy (632)
GLP-1 (1089)
Government (5429)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (278)
Immuno-oncology (43)
Indications (78)
Infectious disease (3255)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (115)
Intellectual property (221)
Interviews (816)
IPO (17946)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10154)
Liver cancer (95)
Longevity (14)
Lung cancer (653)
Lymphoma (363)
Machine learning (40)
Management (66)
Manufacturing (759)
MASH (168)
Medical device (14976)
Medtech (15017)
Mergers & acquisitions (22890)
Metabolic disorders (1309)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (325)
Neuropsychiatric disorders (87)
Neuroscience (2973)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (627)
Opinion (327)
Ovarian cancer (153)
Pain (193)
Pancreatic cancer (206)
Parkinson's disease (275)
Partnered (36)
Patents (473)
Patient recruitment (420)
Peanut (59)
People (66663)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23665)
Phase II (33255)
Phase III (25073)
Pipeline (4023)
Policy (321)
Postmarket research (3554)
Preclinical (10670)
Press Release (72)
Prostate cancer (231)
Psychedelics (53)
Radiopharmaceuticals (292)
Rare diseases (821)
Real estate (7436)
Recruiting (80)
Regulatory (28635)
Reports (65)
Research institute (2718)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (149)
Series A (244)
Series B (178)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (97)
The Weekly (117)
Vaccines (1111)
Venture capital (82)
Weight loss (437)
Women's health (79)
Worklife (21)
Date
Today (65)
Last 7 days (547)
Last 30 days (2377)
Last 365 days (33220)
2025 (32959)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (328)
Arkansas (14)
Asia (51357)
Australia (9021)
California (10901)
Canada (3186)
China (1075)
Colorado (459)
Connecticut (482)
Delaware (329)
Europe (118043)
Florida (1595)
Georgia (353)
Hawaii (3)
Idaho (68)
Illinois (904)
India (62)
Indiana (526)
Iowa (22)
Japan (388)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1402)
Massachusetts (8064)
Michigan (344)
Minnesota (633)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2966)
New Mexico (32)
New York (2908)
North Carolina (1541)
North Dakota (10)
Northern California (5149)
Ohio (332)
Oklahoma (22)
Oregon (52)
Pennsylvania (2208)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4186)
Tennessee (168)
Texas (1717)
United States (39623)
Utah (325)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (922)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,420 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Entheon Announces Letter of Intent with Nutravisor Inc.
December 22, 2025
·
7 min read
Drug pricing
Trump Administration Reaches Pricing Agreements with 9 More Drugmakers
Leerink analysts hailed the deals as a sign that President Trump “is unlikely to attack the industry in 2026.”
December 22, 2025
·
2 min read
·
Nick Paul Taylor
IPO
Radiopharma-Focused Aktis Squeezes in IPO to End Biotech Drought
The biotech, which has a deal with Eli Lilly worth as much as $1.1 billion, is developing two targeted radiopharmaceuticals from its miniprotein radioconjugate platform.
December 22, 2025
·
1 min read
·
Annalee Armstrong
Policy
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy
The biologics center director reportedly became personally involved after the team reviewing the rare blood disorder filing asked for an extension to the CNPV-accelerated timeline.
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Lung cancer
AstraZeneca’s ATR Inhibitor Fails to Improve Survival in Phase III Lung Cancer Trial
Ceralasertib is part of AstraZeneca’s ambitious plan to hit $80 billion in revenue by 2030.
December 22, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
December 22, 2025
·
9 min read
Events
17th Edition Strategic Alliance Management for Pharma
Navigating AI, Globalization, and Integration while Demonstrating Strategic Value
December 22, 2025
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
Jacobio discovered JAB-23E73, which is designed to treat several KRAS mutation subtypes, and is testing the therapy in multiple Phase I trials.
December 22, 2025
·
1 min read
·
Annalee Armstrong
Approvals
Cytokinetics Wins FDA Approval, Clearing Way to Challenge BMS in Heart Disease Market
Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos.
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Business
BioSpace
Editors’ Top 5 Biggest News Stories of the Year
Pfizer and Metsera, Sarepta and uniQure made the list with dramatic tales. The other two spots went to the regulatory challenges facing biopharma under the new administration, especially in the vaccines sector.
December 22, 2025
·
10 min read
·
Annalee Armstrong
1 of 86,742
Next
